美国FDA批准的CAR-T只针对某几种淋巴癌.

来源: 于 2023-12-12 15:33:03 [旧帖] [给我悄悄话] 本文已被阅读：次

. CAR T-cell therapies are FDA approved for:

  • Aggressive relapsed or refractory large B-cell lymphoma including diffuse large B cell lymphoma (DLBCL), primary mediastinal B-cell lymphoma, high-grade B-cell lymphoma, and transformed follicular lymphoma.
  • Relapsed or refractory mantle cell lymphoma
  • Relapsed or refractory follicular lymphoma